Scheme 1. Elaboration of Celecoxiba
Scheme 4. Further Transformations of Sulfonyl Azide 2a
aTol ) tolyl.
Scheme 2. C-Nucleophile Preference
a (a) 2 (1.0 equiv), tert-butyl prop-2-ynylcarbamate (1.0 equiv), NaHCO3
(1.0 equiv), CuSO4 (0.10 equiv), sodium ascorbate (0.20 equiv), 2:1 t-BuOH/
H2O; (b) 2 (1.2 equiv), phenylacetylene (1.0 equiv), diisopropylamine (1.2
equiv), CuI (0.10 equiv), THF; (c) 2 (1.2 equiv), phenylacetylene (1.0 equiv),
(4-bromophenyl)methanol (1.2 equiv), CuI (0.10 equiv), triethylamine (1.2
equiv), CHCl3; (d) 2 (1.0 equiv), malononitrile (1.0 equiv), NaOH (2.0
equiv), Et2O. NaAsc ) sodium ascorbate.
Scheme 3. One-Pot Synthesis of Sulfonyl Azides
nucleophilic enol R-carbon, leading to 25 (Scheme 2).
Although none of the desired sulfonyl azide was detected, a
trace amount of the doubly reacted material 26 was isolated.
corresponding sulfonyl chlorides challenging. This is readily
apparent when one compares two syntheses of the sulfonyl
azide 23, as shown in Scheme 1. Whereas the previous
preparation of this azide involved a four-step sequence
starting from the nitrobenzene derivative 2216 in 20% overall
yield, the improved procedure makes 23 available in a single
step from celecoxib (21, Celebrex), which is itself formed
from the fusion of 4,4,4-trifluoro-1-p-tolylbutane-1,3-dione
and 4-hydrazinylbenzenesulfonamide.17
Although the general procedure is more amenable to the
synthesis of libraries of sulfonyl azides, a one-pot synthesis
whereby a sulfonamide is added directly to the crude reaction
mixture of triflic anhydride and sodium azide can be
employed (Scheme 3).18 Omitting CuSO4,19 triflyl azide was
synthesized in situ from Tf2O and NaN3. In this example,
the conversion of sulfonamide 1 to sulfonyl azide 2 required
68 h instead of 18 h to reach completion.
Similarly to other sulfonyl azides, 2 undergoes a variety
of additional transformations, some of which are shown in
Scheme 4. Illustrating the three-component N-acylsulfona-
mide reaction,5 sulfonyl azide 2 was fused with tert-butyl
prop-2-ynylcarbamate in an aqueous solvent to form N-
acylsulfonamide 27.
As expected, sulfonamides containing carbon nucleophiles,
such as 24, preferentially undergo diazo transfer at the more
(15) To a mixture of sulfonamide 1 (1.43 g, 5.00 mmol), NaHCO3 (1.68.
g), water (6 mL), and 1 M aq CuSO4 (0.20 mL) in a 25 mL Erlenmeyer
flask was added a solution of freshly prepared TfN3 (10 mL, 0.75 M in
toluene, 7.5 mmol), followed by 40 mL of t-BuOH. The flask was loosely
capped, and the solution was stirred vigorously behind a blast shield for
18 h at room temperature. The reaction mixture was transferred to a larger
round-bottom flask, rinsing with water and toluene. With xylenes in the
collection flask, the volatiles were removed by a rotary evaporator, causing
precipitation. Filtration afforded 2 as a yellow powder (1.45 g, 93% yield):
mp 78.5-79.5 °C, Rf ) 0.46 (silica gel, hexanes:EtOAc 8:2); νmax(KBr
disc)/cm-1 2138 (N3), 1589, 1503, 1362 (SO2), 1185, 1161 (SO2), 1097,
1028; 1H NMR (500 MHz, DMSO-d6) δ 8.15 (d, J ) 9.0 Hz, 2H) 7.93 (d,
J ) 9.0 Hz, 2H) 2.43 (s, 3H) 2.24 (s, 3H); 13C NMR (125 MHz, DMSO-
d6) δ 146.7, 144.2, 136.6, 135.2, 128.8, 124.0, 110.4, 11.1, 10.9. Anal.
calcd for C11H10ClN5O2S: C, 42.38; H, 3.23; N, 22.46. Found: C, 42.69;
H, 3.39; N, 22.23.
Analogously, 2 was reacted with in situ generated cop-
per(I) phenylacetylide and diisopropylamine or (4-bromophe-
(17) (a) Jenning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.;
Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.;
Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.;
Burton, E. G.; Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins,
W. E.; Seibert, K.; Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med.
Chem. 1997, 40, 1347–1350. (b) Gosselin, F.; O’Shea, P. D.; Webster, R. A.;
Reamer, R. A.; Tillyer, R. D.; Grabowski, E. J. J. Synlett 2006, 3267–
3270.
(16) (a) Uddin, M. J.; Rao, P. N. P.; Knaus, E. E. Bioorg. Med. Chem.
2003, 11, 5273–5280. (b) Habeeb, A. G.; Rao, P. N. P.; Knaus, E. E. J. Med.
Chem. 2001, 44, 3039–3042. (c) Meerwein, H.; Dittmar, G.; Gollner, R.;
Hafner, K.; Mensch, F.; Steinfort, O. Chem. Ber. 1957, 90, 841–852.
(18) The authors would like to thank a reviewer for suggesting the
inclusion of this example.
(19) Wear, J. O. J. Chem. Educ. 1975, 52, A23–A25.
Org. Lett., Vol. 10, No. 16, 2008
3387